World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
47
Citations
9592
World Ranking
4501
National Ranking
2035

Brent E. Palmer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Brent E. Palmer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 129 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Brent E. Palmer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Brent E. Palmer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 47 D-Index — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Brent E. Palmer is affiliated with the University of Colorado Denver in the United States. Their research spans across Medicine and Biochemistry, Genetics and Molecular Biology, with a significant focus on Infectious Diseases, Molecular Biology, Immunology, Virology, and Emergency Medicine as key subfields.

Their research explores a variety of topics including gut microbiota and health, HIV research and treatment, HIV-related health complications and treatments, SARS-CoV-2 and COVID-19 research, long-term effects of COVID-19, HIV/AIDS research and interventions, and the role of immune cells in cancer.

Brent E. Palmer has published extensively, with notable papers including:

  • Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion, 2021, Proceedings of the National Academy of Sciences
  • SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2, 2022, PLoS Pathogens
  • Can gut microbiota of men who have sex with men influence HIV transmission?, 2020, Gut Microbes
  • Intestinal microbial communities and Holdemanella isolated from HIV+/− men who have sex with men increase frequencies of lamina propria CCR5 + CD4 + T cells, 2021, Gut Microbes
  • SARS-CoV-2 infection relaxes peripheral B cell tolerance, 2022, The Journal of Experimental Medicine

Their frequent co-authors include C. Preston Neff, Catherine Lozupone, Thomas Campbell, Jennifer M. Schneider, and Suzanne Fiorillo.

The scientist's publications appear regularly in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Immunology
  • Viral Immunology
  • Gut Microbes
  • Frontiers in Immunology

Best Publications

  • IL-37 is a fundamental inhibitor of innate immunity.

    Marcel F Nold;Claudia A Nold-Petry;Claudia A Nold-Petry;Jarod A Zepp;Brent E Palmer

  • Negative Immune Regulator Tim-3 Is Overexpressed on T Cells in Hepatitis C Virus Infection and Its Blockade Rescues Dysfunctional CD4+ and CD8+ T Cells

    Lucy Golden-Mason;Brent E. Palmer;Nasim Kassam;Lisa Townshend-Bulson

  • Alterations in the Gut Microbiota Associated with HIV-1 Infection

    Catherine A. Lozupone;Marcella Li;Thomas B. Campbell;Sonia C. Flores

  • Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction

    Lucy Golden-Mason;Brent Palmer;Jared Klarquist;John A. Mengshol

  • Programmed Death 1 Expression on HIV-Specific CD4+ T Cells Is Driven by Viral Replication and Associated with T Cell Dysfunction

    Michelle D’Souza;Andrew P. Fontenot;Doug G. Mack;Catherine Lozupone

  • Antigen-presenting intratumoral B cells affect CD4+ TIL phenotypes in non-small cell lung cancer patients

    Tullia C. Bruno;Peggy J. Ebner;Brandon L. Moore;Olivia G. Squalls

  • Influence of Plasma Viremia on Defects in Number and Immunophenotype of Blood Dendritic Cell Subsets in Human Immunodeficiency Virus 1–Infected Individuals

    Michelle A. Barron;Naomi Blyveis;Brent E. Palmer;Samantha MaWhinney

  • Extracellular forms of IL-37 inhibit innate inflammation in vitro and in vivo but require the IL-1 family decoy receptor IL-1R8.

    Suzhao Li;C. Preston Neff;Kristina Barber;Jaewoo Hong

  • Widespread colonization of the lung by Tropheryma whipplei in HIV infection.

    Catherine Lozupone;Adela Cota-Gomez;Brent E. Palmer;Derek J. Linderman

  • HIV-1 infection and CD4 T cell depletion in the humanized Rag2 -/- γc -/- (RAG-hu) mouse model

    Bradford K Berges;William H Wheat;Brent E Palmer;Elizabeth Connick

  • Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction.

    Brent E. Palmer;Naomi Blyveis;Andrew P. Fontenot;Cara C. Wilson

  • Association of Functional Impairment with Inflammation and Immune Activation in HIV Type 1–Infected Adults Receiving Effective Antiretroviral Therapy

    Kristine M. Erlandson;Amanda A. Allshouse;Catherine M. Jankowski;Eric J. Lee

  • HIV-induced alteration in gut microbiota: driving factors, consequences, and effects of antiretroviral therapy.

    Catherine A Lozupone;Matthew E Rhodes;Charles P Neff;Andrew P Fontenot

  • Targeting tumor-derived NLRP3 reduces melanoma progression by limiting MDSCs expansion

    Isak W. Tengesdal;Isak W. Tengesdal;Dinoop R. Menon;Douglas G. Osborne;Charles P. Neff

  • An exploration of Prevotella -rich microbiomes in HIV and men who have sex with men

    Abigail J. S. Armstrong;Michael Shaffer;Nichole M. Nusbacher;Christine Griesmer

  • Safety and Efficacy of a Lentiviral Vector Containing Three Anti-HIV Genes—CCR5 Ribozyme, Tat-rev siRNA, and TAR Decoy—in SCID-hu Mouse–Derived T Cells

    Joseph S Anderson;Ming Jie Li;Brent Palmer;Leila Remling

  • Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals.

    James M. Beck;Patrick D. Schloss;Arvind Venkataraman;Homer Twigg

  • Galectin-9 Functionally Impairs Natural Killer Cells in Humans and Mice

    Lucy Golden-Mason;Rachel H. McMahan;Rachel H. McMahan;Michael Strong;Richard Reisdorph

  • Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties.

    C. Preston Neff;Matthew E. Rhodes;Kathleen L. Arnolds;Colm B. Collins

  • Discordance between frequency of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-producing CD4(+) T cells and HIV-1-specific lymphoproliferation in HIV-1-infected subjects with active viral replication.

    B. E. Palmer;E. Boritz;N. Blyveis;C. C. Wilson

  • Regulation of virus-specific CD4+ T cell function by multiple costimulatory receptors during chronic HIV infection.

    Afework Kassu;Roland A. Marcus;Michelle B. D’Souza;Elizabeth A. Kelly-McKnight

  • Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes.

    Cara C. Wilson;Brent Palmer;Scott Southwood;John Sidney

Frequent Co-Authors

Andrew P. Fontenot
Andrew P. Fontenot University of Colorado Anschutz Medical Campus
Catherine A. Lozupone
Catherine A. Lozupone University of Colorado Anschutz Medical Campus
Cara C. Wilson
Cara C. Wilson University of Colorado Anschutz Medical Campus
Charles A. Dinarello
Charles A. Dinarello University of Colorado Anschutz Medical Campus
Martin D. McCarter
Martin D. McCarter University of Colorado Anschutz Medical Campus
Ramesh Akkina
Ramesh Akkina Colorado State University
Hugo R. Rosen
Hugo R. Rosen University of Southern California
Edward N. Janoff
Edward N. Janoff University of Colorado Denver
Rob Knight
Rob Knight University of California, San Diego
Elizabeth Connick
Elizabeth Connick University of Arizona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying immunology in the USA opens doors to various health science careers, many of which can be enhanced through online education. For those interested in nursing, pursuing a nurse practitioner accelerated program can fast-track your path to advanced clinical roles, integrating immunology expertise with patient care.

Individuals with no prior nursing experience can also explore flexible options like online RN programs for non nurses in Florida, making it easier to transition into nursing while complementing their immunology knowledge.

When considering entry points into nursing, it’s helpful to know about the easiest accelerated nursing programs to get into. These programs can provide quicker, more accessible routes into nursing careers that work well with an immunology background.

For those focused on foundational nursing roles, identifying the easiest LPN programs to get into is crucial. Licensed Practical Nurse programs offer practical experience that often complements immunology in healthcare settings, making these combined skills highly valuable.

Best Scientists Citing Brent E. Palmer

Trending Scientists

Recently Published Articles